|
Volumn 102, Issue 2, 2001, Pages 107-114
|
Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients
|
Author keywords
Diabetes; Endothelial dysfunction; Hypertension; Nitric oxide; Platelet activation; von Willebrand factor
|
Indexed keywords
ARGININE;
ENDOTHELIN 1;
GLYCOSYLATED HEMOGLOBIN;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
PADGEM PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
VON WILLEBRAND FACTOR;
ADULT;
AGED;
ARTICLE;
BIOAVAILABILITY;
BLOOD PRESSURE;
BODY MASS;
CONTROLLED STUDY;
DIET;
DISEASE MARKER;
ENDOTHELIUM LESION;
ENZYME ACTIVATION;
FEMALE;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPERTENSION;
INSULIN BLOOD LEVEL;
INSULIN RESISTANCE;
INSULINEMIA;
MAJOR CLINICAL STUDY;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
THROMBOCYTE ACTIVATION;
VASODILATATION;
AGED;
BLOOD PRESSURE;
CASE-CONTROL STUDIES;
DIABETES MELLITUS, TYPE 2;
ENDOTHELIUM, VASCULAR;
FEMALE;
HUMANS;
HYPERTENSION;
MALE;
MIDDLE AGED;
NITRIC OXIDE;
PLATELET ACTIVATION;
THROMBOPHILIA;
TUMOR NECROSIS FACTOR-ALPHA;
VON WILLEBRAND FACTOR;
|
EID: 0035871024
PISSN: 00493848
EISSN: None
Source Type: Journal
DOI: 10.1016/S0049-3848(01)00237-7 Document Type: Article |
Times cited : (79)
|
References (35)
|